A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21
Titel:
A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21
Auteur:
Slovin, Susan F. Ragupathi, Govind Fernandez, Celina Jefferson, Matthew P. Diani, Meghan Wilton, Andrew S. Powell, Shemeeakah Spassova, Maria Reis, Celso Clausen, Henrick Danishefsky, Samuel Livingston, Philip Scher, Howard I.